Stephen L. Newman
Private Equity Investor at JDRF T1D Fund
Stephen L. Newman active positions
| Companies | Position | Start | End |
|---|---|---|---|
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | - | - |
Career history of Stephen L. Newman
Former positions of Stephen L. Newman
| Companies | Position | Start | End |
|---|---|---|---|
CentraForce LLC
 CentraForce LLC Miscellaneous Commercial ServicesCommercial Services CentraForce LLC engages in audience-centric marketing. The company’s capabilities allow serving teams responsible for research, insights, strategic planning, media planning and analytics. Its clients include retail, nonprofit, media, health, government and advocacy. The company was founded by Jon Pelzer and Thomas Stevenson in 2011 and is headquartered in Austin, TX. | Chairman | 2015-06-30 | 2022-07-31 |
| Chief Tech/Sci/R&D Officer | 2015-06-30 | 2022-07-31 | |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Director/Board Member | 2016-09-05 | 2018-06-30 |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Director/Board Member | 2014-06-30 | 2016-05-31 |
| Chairman | 2016-06-30 | 2018-05-31 | |
| HANSEN MEDICAL, INC. | Director/Board Member | 2012-06-30 | 2017-06-30 |
| Federal Reserve Bank of Atlanta | Corporate Officer/Principal | 2007-12-31 | 2016-05-31 |
| CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 2013-03-13 | 2014-03-18 |
| Independent Dir/Board Member | 2013-03-12 | 2014-03-18 | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Director/Board Member | 2012-07-23 | 2013-10-23 |
| TENET HEALTHCARE CORPORATION | Director/Board Member | 2012-04-03 | - |
| Chief Operating Officer | 1999-01-31 | 2012-04-03 | |
| ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Stephen L. Newman
| Rutgers State University of New Jersey | Undergraduate Degree |
| A.B. Freeman School of Business | Masters Business Admin |
| The University of Tennessee Health Science Center | Doctorate Degree |
| Tulane University (Louisiana) | Masters Business Admin |
Statistics
International
| United States | 19 |
Operational
| Director/Board Member | 7 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Services | 5 |
| Consumer Services | 5 |
| Health Technology | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TENET HEALTHCARE CORPORATION | Health Services |
| Private companies | 13 |
|---|---|
Federation of American Hospitals
 Federation of American Hospitals Miscellaneous Commercial ServicesCommercial Services Federation of American Hospitals operates as a representative and trade association for community hospitals and health systems. The private company is based in Washington. The American company was founded by Martin S. Rash. Charles N. Kahn has been the CEO of the company since 2001. | Commercial Services |
HCA, Inc.
 HCA, Inc. Hospital/Nursing ManagementHealth Services HCA, Inc. engages in the provision of healthcare services. The firm specializes in general surgery, cardiology, oncology, neurology, orthopedics, and obstetrics services. The company was founded by Thomas Frist, Sr., Jack Massey, and Thomas Frist, Jr. in 1968 and is headquartered in Nashville, TN. | Health Services |
Dayton Children's Hospital
 Dayton Children's Hospital Hospital/Nursing ManagementHealth Services Dayton Children's Hospital operates as a pediatric referral center. Its services include cardiology, endocrinology and diabetes, gastroenterology, neurology, orthopedics, pulmonary, rehabilitation, and pediatric surgery. The company was founded by Annae Barney Gorman in 1919 and is headquartered in Dayton, OH. | Health Services |
| Norton Audubon Hospital | |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Hansen Medical, Inc.
 Hansen Medical, Inc. Medical SpecialtiesHealth Technology Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for positioning, manipulation, and stable control of catheters and catheter-based technologies. It offers Sensei Robotic Catheter System which allows physicians to instinctively navigate flexible catheters with stability and control in interventional procedures within the atria heart chambers. The company was founded by Frederic H. Moll, Daniel T. Wallace, Marvin J. Slepian, and Robert G. Younge on November 18, 2002 and is headquartered in Redwood City, CA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Touro Infirmary
 Touro Infirmary Hospital/Nursing ManagementHealth Services Touro Infirmary, Inc. offers healthcare services It offers acute case management, ambulatory treatment, cardiology, diabetes, emergency, family birthing center and women's health, imaging, oncology, orthopedics, physical therapy, senior, surgery, rehabilitation, wellness, and wound care services. The firm provides cancer programs, heart and vascular center, and ambulatory surgery center services. The company was founded in 1852 and is headquartered in New Orleans, LA. | Health Services |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Commercial Services |
| Federal Reserve Bank of Atlanta | Government |
CentraForce LLC
CentraForce LLC Miscellaneous Commercial ServicesCommercial Services CentraForce LLC engages in audience-centric marketing. The company’s capabilities allow serving teams responsible for research, insights, strategic planning, media planning and analytics. Its clients include retail, nonprofit, media, health, government and advocacy. The company was founded by Jon Pelzer and Thomas Stevenson in 2011 and is headquartered in Austin, TX. | Commercial Services |
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Health Technology |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
- Stock Market
- Insiders
- Stephen L. Newman
- Experience
